A physics- and spatially informed diffusion model accelerates Monte Carlo–level dose estimation for CyberKnife radiotherapy using planning CT and anatomical data.
Key Details
- 1The PSIDMViT model integrates planning CT, finite-size pencil beam dose distributions, and distance maps for dose prediction.
- 2Tested retrospectively in 251 CyberKnife patients (117 head-and-neck, 76 lung, 58 liver).
- 3Achieved 3D Gamma passing rates of 98.0% for head-and-neck, 94.0% for lung, and 95.0% for liver cases (1%/1 mm/10% criterion).
- 4Reduced dose computation time from about 1 hour to 18 minutes per plan versus Monte Carlo methods.
- 5Outperformed conventional finite-size pencil beam and baseline deep-learning models in accuracy.
- 6External and multi-institutional validation remains needed.
Why It Matters
Fast, Monte Carlo–consistent dose prediction can make accurate, individualized radiotherapy planning more feasible in clinical routine, improving workflow efficiency for high-precision treatments. This approach illustrates how integrating imaging, physics, and AI can address major clinical bottlenecks.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.